Self-glycolipids modulate dendritic cells changing the cytokine profiles of committed autoreactive T cells

Karsten Buschard, Jan-Eric Månsson, Bart O Roep, Tatjana Nikolic

Abstract

The impact of glycolipids of non-mammalian origin on autoimmune inflammation has become widely recognized. Here we report that the naturally occurring mammalian glycolipids, sulfatide and β-GalCer, affect the differentiation and the quality of antigen presentation by monocyte-derived dendritic cells (DCs). In response to sulfatide and β-GalCer, monocytes develop into immature DCs with higher expression of HLA-DR and CD86 but lower expression of CD80, CD40 and CD1a and lower production of IL-12 compared to non-modulated DCs. Self-glycolipid-modulated DCs responded to lipopolysaccharide (LPS) by changing phenotype but preserved low IL-12 production. Sulfatide, in particular, reduced the capacity of DCs to stimulate autoreactive Glutamic Acid Decarboxylase (GAD65) - specific T cell response and promoted IL-10 production by the GAD65-specific clone. Since sulfatide and β-GalCer induced toll-like receptor (TLR)-mediated signaling, we hypothesize that self-glycolipids deliver a (tolerogenic) polarizing signal to differentiating DCs, facilitating the maintenance of self-tolerance under proinflammatory conditions.

OriginalsprogEngelsk
TidsskriftPLoS One
Vol/bind7
Udgave nummer12
Sider (fra-til)e52639
ISSN1932-6203
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Self-glycolipids modulate dendritic cells changing the cytokine profiles of committed autoreactive T cells'. Sammen danner de et unikt fingeraftryk.

Citationsformater